Compare DRH & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRH | BHC |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | 35 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | N/A | 1996 |
| Metric | DRH | BHC |
|---|---|---|
| Price | $10.89 | $5.54 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | ★ $10.38 | $8.00 |
| AVG Volume (30 Days) | 1.7M | ★ 1.8M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.51% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $3.44 | $4.61 |
| Revenue Next Year | $2.42 | N/A |
| P/E Ratio | $38.41 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.40 | $4.41 |
| 52 Week High | $10.90 | $8.69 |
| Indicator | DRH | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 62.23 | 50.13 |
| Support Level | $9.10 | $5.48 |
| Resistance Level | $10.90 | $5.62 |
| Average True Range (ATR) | 0.23 | 0.20 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 87.86 | 41.54 |
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.